These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7036348)

  • 1. Fibrin: structure and interactions.
    Hermans J; McDonagh J
    Semin Thromb Hemost; 1982 Jan; 8(1):11-24. PubMed ID: 7036348
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrinogen and fibrin.
    Doolittle RF
    Annu Rev Biochem; 1984; 53():195-229. PubMed ID: 6383194
    [No Abstract]   [Full Text] [Related]  

  • 3. The assembly and structure of the fibrin clot.
    Mosesson MW
    Nouv Rev Fr Hematol (1978); 1992; 34(1):11-6. PubMed ID: 1523091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two families of synthetic peptides that enhance fibrin turbidity and delay fibrinolysis by different mechanisms.
    Pandi L; Kollman JM; Lopez-Lira F; Burrows JM; Riley M; Doolittle RF
    Biochemistry; 2009 Aug; 48(30):7201-8. PubMed ID: 19588915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of critical residues on thrombin mediating its interaction with fibrin.
    Hall SW; Gibbs CS; Leung LL
    Thromb Haemost; 2001 Dec; 86(6):1466-74. PubMed ID: 11776315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probing the beta-chain hole of fibrinogen with synthetic peptides that differ at their amino termini.
    Doolittle RF; Pandi L
    Biochemistry; 2007 Sep; 46(35):10033-8. PubMed ID: 17688324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis.
    Stucki B; Schmutz P; Schmid L; Haeberli A; Lämmle B; Furlan M
    Thromb Haemost; 1999 Feb; 81(2):268-74. PubMed ID: 10064005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular cloning and expression of a functional snake venom serine proteinase, with platelet aggregating activity, from the Cerastes cerastes viper.
    Dekhil H; Wisner A; Marrakchi N; El Ayeb M; Bon C; Karoui H
    Biochemistry; 2003 Sep; 42(36):10609-18. PubMed ID: 12962484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing the distance between the two binding sites of hirudin for its interaction with the active site and the fibrin(ogen)-binding site of alpha-thrombin.
    Wagner U; Schmitz T; Otte M; Dodt J
    Biomed Biochim Acta; 1991; 50(4-6):707-10. PubMed ID: 1801747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin.
    Doolittle RF; Pandi L
    Biochemistry; 2006 Feb; 45(8):2657-67. PubMed ID: 16489759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence of fibrinogen proteolysis and platelet release after intrauterine infusion of hypertonic saline.
    Nossel HL; Wasser J; Kaplan KL; LaGamma KS; Yudelman I; Canfield RE
    J Clin Invest; 1979 Nov; 64(5):1371-8. PubMed ID: 500818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical significance of fibrinogen/fibrin degradation products (F/F DP)].
    Alakhverdian R
    Vutr Boles; 1979; 18(3):160-7. PubMed ID: 89851
    [No Abstract]   [Full Text] [Related]  

  • 13. [Role of heparin in the process of blood coagulation and fibrinolysis].
    Liapina LA
    Usp Sovrem Biol; 1977; 84(3):338-52. PubMed ID: 343416
    [No Abstract]   [Full Text] [Related]  

  • 14. Thrombin interactions with fibrinogen and fibrin.
    Mosesson MW
    Semin Thromb Hemost; 1993; 19(4):361-7. PubMed ID: 8140428
    [No Abstract]   [Full Text] [Related]  

  • 15. On the structure of functional sites in fibrinogen.
    Henschen A
    Thromb Res; 1983; Suppl 5():27-39. PubMed ID: 6225216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia.
    Sauls DL; Lockhart E; Warren ME; Lenkowski A; Wilhelm SE; Hoffman M
    Biochemistry; 2006 Feb; 45(8):2480-7. PubMed ID: 16489740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human fibrinogen.
    Shafer JA; Higgins DL
    Crit Rev Clin Lab Sci; 1988; 26(1):1-41. PubMed ID: 3286116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal binding of calcium to five fibrinogen variants with mutations in the carboxy terminal part of the gamma-chain.
    Furlan M; Stucki B; Steinmann C; Jungo M; Lämmle B
    Thromb Haemost; 1996 Sep; 76(3):377-83. PubMed ID: 8883274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathohysiological and biochemical aspects of the diagnosis of thrombosis].
    Markwárdt F; Eimleitung I
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(2):109-14. PubMed ID: 50974
    [No Abstract]   [Full Text] [Related]  

  • 20. Crystal structures of fragments D and double-D from fibrinogen and fibrin.
    Doolittle RF; Spraggon G; Everse SJ
    Thromb Haemost; 1999 Aug; 82(2):271-6. PubMed ID: 10605713
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.